Immunological Mechanisms in Periodontal Disease

Periodontal disease arises from a complex interplay between a dysbiotic microbial biofilm and the host immune response. Innate mechanisms—including neutrophils, macrophages and dendritic cells—recognise microbial patterns and release cytokines that recruit adaptive lymphocytes. CD4+ T-cell subsets such as pro-inflammatory TH17 cells drive RANKL-mediated osteoclastogenesis and alveolar bone resorption, while regulatory T cells (Tregs) act to curb excessive inflammation and protect tissue integrity. B cells contribute to local immunity but may exacerbate bone loss via RANKL secretion. Chronic inflammation destabilises tissue homeostasis, and failure to resolve inflammation perpetuates tissue destruction. Pro-resolving lipid mediators, cytokine networks and immune regulation are central to disease progression. Understanding these mechanisms is essential for global public health, given the links between periodontal inflammation and systemic conditions such as diabetes and cardiovascular disease.

Research from Nature Portfolio

Recent studies have explored the dual roles of T-cell subsets in periodontal immunity. Foundational work on specialised bone-damaging TH17 cells demonstrated that these lymphocytes not only eradicate invading bacteria but also induce controlled alveolar bone loss to contain local infection. Further investigation in experimental periodontitis revealed that chronic inflammation destabilises Tregs, reducing their Foxp3 expression and anti-osteoclastogenic capacity. These unstable Tregs fail to suppress osteoclast differentiation effectively, tipping the balance towards Th17-driven bone destruction. Together, these findings underscore the delicate equilibrium between protective and pathological immune responses in periodontal tissues.

Immunological Mechanisms in Periodontal Disease publication trend

The graph below shows the total number of articles in immunological mechanisms in periodontal disease across all publications each year (not limited to Nature Index journals).

Technical terms

Alveolar bone resorption: the process by which bone supporting the teeth is broken down by osteoclasts, leading to tooth loss.

TH17 cells: a subset of CD4+ T-helper cells that produce interleukin-17 and drive pro-inflammatory responses contributing to bone destruction.

Regulatory T cells (Tregs): immunosuppressive CD4+ T cells that express Foxp3 and help maintain immune tolerance and limit tissue damage.

RANKL: a cytokine ligand of the receptor activator of nuclear factor kappa-B, essential for osteoclast differentiation and activation.

Pro-resolving lipid mediators (resolvins): bioactive molecules derived from fatty acids that actively terminate inflammation and promote tissue homeostasis.

Dysbiosis: an imbalance in the microbial community in the oral cavity that triggers pathological immune responses.

Osteoclastogenesis: the formation and activation of osteoclasts, cells responsible for bone degradation.

References

1. Oral microbiota–host interaction: the chief culprit of alveolar bone resorption. Frontiers in Immunology (2024).
2. Host defense against oral microbiota by bone-damaging T cells. Nature Communications (2018).
3. Regulatory T cell phenotype and anti-osteoclastogenic function in experimental periodontitis. Scientific Reports (2020).
4. RvE1 Impacts the Gingival Inflammatory Infiltrate by Inhibiting the T Cell Response in Experimental Periodontitis. Frontiers in Immunology (2021).
5. Metabolic Disturbance and Th17/Treg Imbalance Are Associated With Progression of Gingivitis. Frontiers in Immunology (2021).